Related Experiment Videos
Polio vaccines: WHO position paper, March 2016-recommendations
1WHO, Immunization, Vaccines and Biologicals, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Vaccine
|November 30, 2016
Summary
The World Health Organization recommends inactivated polio vaccine (IPV) in routine immunization to prevent polio resurgence after oral polio vaccine (OPV) type 2 withdrawal. This strategy supports global polio eradication efforts.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- The World Health Organization (WHO) issues updated position papers on vaccines for diseases with international public health impact.
- This paper replaces the 2014 WHO polio vaccine position paper, reflecting the April 2016 global switch from trivalent to bivalent oral polio vaccine (OPV).
Purpose of the Study:
- To present the WHO's current recommendations on polio vaccine usage.
- To outline strategies for mitigating polio re-emergence risks post-oral polio vaccine (OPV) type 2 withdrawal.
Main Methods:
- The recommendations are based on evidence reviewed by the WHO's Strategic Advisory Group of Experts on Immunization (SAGE).
- The position paper summarizes scientific evidence, including grading tables and evidence-to-recommendation tables.
Main Results:
- The WHO recommends the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules.
- This strategy aims to address the potential risk of type 2 poliovirus re-emergence after the withdrawal of Sabin type 2 strains from OPV.
Conclusions:
- The updated recommendations support global polio eradication initiatives.
- The position paper guides Member States on polio vaccine policy for large-scale immunization programs.